Seno Medical

Novel diagnostic imaging for the early diagnosis of breast cancer.

[Seno Medical @senomedical]

Breast Cancer Awareness Month reminds us why better tools matter.

Imagio® represents a milestone in breast imaging as the first and only FDA-approved opto-acoustic imaging system for breast cancer diagnosis.

Awareness starts the conversation. Innovation helps move it forward.

[Seno Medical @senomedical]

More than structure.

Ultrasound provides an important view of breast anatomy. Imagio® delivers opto-acoustic imaging against the familiar backdrop of ultrasound to add functional information to the view.

See what Imagio adds : https://t.co/ODR35X6wDT

#BreastCacerAwarenessMonth

[Seno Medical @senomedical]

Not every abnormal finding is cancer.

This Breast Cancer Awareness Month, we're focusing on that space between clearly benign & clearly suspicious & how additional functional information may help clinicians navigate it.

The gray zone deserves a closer look with OA imaging.

[Seno Medical @senomedical]

It's Breast Cancer Awareness Month.

Awareness starts the conversation. But what happens after something is found matters, too.

This month, we're looking beyond the mammogram to explore the questions that can follow an abnormal or finding and technology designed to give more.

[Seno Medical @senomedical]

Behind every “let's take another look” is a person waiting for an answer.

For patients, the diagnostic journey isn't just about images. It's about conversations, decisions and uncertainty.

For clinicians, having the right information can help make those decisions more informed.

[Seno Medical @senomedical]

Indeterminate breast findings demand more than uncertainty.

Imagio® adds functional information to ultrasound, providing another layer of insight for evaluating breast masses in the diagnostic gray zone.

→ Explore Imagio®: https://t.co/ODR35X74tr

#Imagio #BreastCancer

[Seno Medical @senomedical]

“The question isn't always, ‘Is this cancer?’ Sometimes it's, ‘What additional information do I need before deciding what comes next?’”

That distinction matters in the diagnostic gray zone.

Imagio adds functional information giving clinicians a new critical layer of information

[Seno Medical @senomedical]

“Let's watch it” can be a difficult sentence to hear.

For a clinician, it can be a reasonable next step. For a patient, it can mean more questions and more waiting.

Behind every indeterminate finding is a person waiting to understand what comes next.

Explore Imagio®.

[Seno Medical @senomedical]

Ultrasound alone shows structure. What else could you learn from a lesion?

Imagio® fuses opto-acoustic imaging with background ultrasound to provide functional information in a single imaging system.

It's a different way of looking at breast findings.

[Seno Medical @senomedical]

Not every breast finding comes with a definitive answer. Some findings are clearly benign. Others are clearly suspicious. But between those two points is a gray zone where clinicians need more information to determine what comes next.

Learn how Imagio® is designed to help.

[Seno Medical @senomedical]

See Imagio® in Action. The Imagio® Roadshow is coming to you.

Experience how Imagio® imaging can bring new functional information to breast imaging and help provide greater clarity when a breast mass falls into the gray zone.

Ready to experience Imagio®?
#Imagio #BreastCancer

[Seno Medical @senomedical]

We’re heading to Maastricht! 🇳🇱

W are excited to be part of EUSOBI 2026, October 1–3.

We’ll be connecting with breast imaging professionals from across Europe and sharing how Imagio® is bringing new information to the evaluation of breast masses.

📍 Visit us at Booth #M04

[Seno Medical @senomedical]

"Probably benign" doesn't always feel that way to patients. For women with BIRADS 3 lesions, the wait-and-watch approach can be agonizing.
Imagio gives radiologists additional functional information to downgrade findings & give patients the reassurance & clarity they need sooner

[Seno Medical @senomedical]

How does Imagio® actually work?

OA Imaging — Imagio® combines opto-acoustic imaging with ultrasound in a single handheld probe.

Blood mapping — Resulting image shows oxygenated vs. deoxygenated blood distribution; a key indicator of malignancy.

Visit https://t.co/rMykrG2h1p

[Seno Medical @senomedical]

As breast cancer screening guidelines continue to evolve & debate when & how to screen, one thing is clear: when a mass is found, radiologists need the best possible tools to characterize it accurately.

Imagio® steps in at the diagnostic stage adding functional insight.

[Seno Medical @senomedical]

$2.18 billion.

That's the annual cost of false-positive breast biopsies in the US alone.

Imagio® was built to address this gap head-on, giving clinicians the diagnostic confidence to rule out malignancy without an invasive procedure, and giving patients answers sooner.

#Imagio

[Seno Medical @senomedical]

Breast cancer doesn't wait.

Neither should patients.

Imagio® delivers real-time diagnostic imaging so radiologists can assess a mass as benign or malignant in a single exam. No biopsy required.

This is what the next chapter of breast imaging looks like.

#Imagio #BreastCancer

[Seno Medical @senomedical]

No radiation. No contrast agents. No compromise on information. Imagio® delivers real-time functional & anatomical breast imaging using light & sound, not ionizing radiation.
For patients and providers who want answers without added risk, this is the future of breast diagnostics

[Seno Medical @senomedical]

71% of breast biopsies come back negative.

That's millions of women enduring needles, stress, and a median 48-day wait for a benign result.

Imagio® by SenoMedical changes the math. Real-time imaging. No needles. No radiation.

Learn more → https://t.co/wyrlsyyFCN

#Imagio

[Seno Medical @senomedical]

What if a single exam could tell you whether a breast mass is benign or malignant without a biopsy, without radiation, and without the weeks of waiting?

That's Imagio®.

Learn more at https://t.co/wyrlsyyFCN

#Imagio #BreastCancer #BreastHealth #Radiology #WomensHealth